Pharmaceutical Executive November 28, 2023
Don Tracy, Associate Editor

Law aims to mitigate ongoing global drug shortages.

US President Joe Biden has announced approximately 30 new actions aimed at strengthening supply chains critical to national interests. According to the White House, these actions aim to help Americans get necessary products when they need them. Furthermore, the president has invoked the Defense Production Act, enabling investment in domestic manufacturing of essential medicines, medical countermeasures, and critical inputs that have been deemed as essential to the national defense.1

“And today, we’re coming together to ask a simple question: What’s next?What can we do? What must we do to keep making progress to keep our supply chain stable and secure in the long term, to keep preserving that breathing room—that little bit...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, HHS, Pharma, Pharma / Biotech, Supply Chain, Technology
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
Walgreens to go private in $10B deal
The essential biotech news stories of the day
GLP-1s and total joint replacement: 10 things to know
The pharmacy change 'key to your future existence as a health plan'

Share This Article